$9.24
0.252.78%
Ult. Agg.: Oct 30, 4:48 PM
ORIC Pharmaceuticals (ORIC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.36 | $-0.32 | $-0.36 | $-0.40 |
| Actual | $-0.38 | $-0.34 | $-0.30 | $-0.33 |
| Surprise | -5.56% | -6.25% | +16.7% | +17.5% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.39 | $-0.40 | $-0.44 | $-0.47 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 3, 2026 | $-0.38 | $-0.36 | -5.56 % |
| Q1 | May 4, 2026 | $-0.34 | $-0.32 | -6.25 % |
| Q4 | Feb 23, 2026 | $-0.30 | $-0.36 | 16.7 % |
| Q3 | Nov 13, 2025 | $-0.33 | $-0.40 | 17.5 % |